Activation of NK cell cytotoxicity

Arase, 2002, Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors, Science, 296, 1323, 10.1126/science.1070884 Azuma, 1992, Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line, J. Immunol., 149, 1115, 10.4049/jimmunol.149.4.1115 Baker, 1994, The genes encoding NK cell granule serine proteases, human tryptase-2 (TRYP2) and human granzyme A (HFSP), both map to chromosome 5q11–q12 and define a new locus for cytotoxic lymphocyte granule tryptases, Immunogenetics, 40, 235, 10.1007/BF00167085 Beresford, 1999, Granzyme A loading induces rapid cytolysis and a novel form of DNA damage independently of caspase activation, Immunity, 10, 585, 10.1016/S1074-7613(00)80058-8 Biron, 1999, Natural killer cells in antiviral defense: function and regulation by innate cytokines, Annu. Rev. Immunol., 17, 189, 10.1146/annurev.immunol.17.1.189 Bradley, 1998, Role of spontaneous and interleukin-2-induced natural killer cell activity in the cytotoxicity and rejection of Fas+ and Fas− tumor cells, Blood, 92, 4248, 10.1182/blood.V92.11.4248 Brady, 2004, IL-21 induces the functional maturation of murine NK cells, J. Immunol., 172, 2048, 10.4049/jimmunol.172.4.2048 Brown, 2001, Vital involvement of a natural killer cell activation receptor in resistance to viral infection, Science, 292, 934, 10.1126/science.1060042 Browne, 1999, Cytosolic delivery of granzyme B by bacterial toxins: evidence that endosomal disruption, in addition to transmembrane pore formation, is an important function of perforin, Mol. Cell. Biol., 19, 8604, 10.1128/MCB.19.12.8604 Carbone, 1997, A new mechanism of NK cell cytotoxicity activation: the CD40–CD40 ligand interaction, J. Exp. Med., 185, 2053, 10.1084/jem.185.12.2053 Cerwenka, 2000, Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice, Immunity, 12, 721, 10.1016/S1074-7613(00)80222-8 Cerwenka, 2001, Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo, Proc. Natl. Acad. Sci. U.S.A., 98, 11521, 10.1073/pnas.201238598 Cerwenka, 2001, Natural killer cells, viruses and cancer, Nat. Rev. Immunol., 1, 41, 10.1038/35095564 Clayberger, 2003, Granulysin, Curr. Opin. Immunol., 15, 560, 10.1016/S0952-7915(03)00097-9 Cosman, 2001, ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor, Immunity, 14, 123, 10.1016/S1074-7613(01)00095-4 Cretney, 2002, Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice, J. Immunol., 168, 1356, 10.4049/jimmunol.168.3.1356 Davis, 2001, Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity, Eur. J. Immunol., 31, 39, 10.1002/1521-4141(200101)31:1<39::AID-IMMU39>3.0.CO;2-1 Degli-Esposti, 1999, To die or not to die – the quest of the TRAIL receptors, J. Leukoc. Biol., 65, 535, 10.1002/jlb.65.5.535 Diefenbach, 2000, Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages, Nat. Immunol., 1, 119, 10.1038/77793 Diefenbach, 2001, Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity, Nature, 413, 165, 10.1038/35093109 Diefenbach, 2002, Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D, Nat. Immunol., 3, 1142, 10.1038/ni858 Dokun, 2001, Specific and nonspecific NK cell activation during virus infection, Nat. Immunol., 2, 951, 10.1038/ni714 Ebnet, 1995, Granzyme A-deficient mice retain potent cell-mediated cytotoxicity, EMBO J., 14, 4230, 10.1002/j.1460-2075.1995.tb00097.x Fan, 2003, Cleaving the oxidative repair protein Ape1 enhances cell death mediated by granzyme A, Nat. Immunol., 4, 145, 10.1038/ni885 Gamen, 1998, Granulysin-induced apoptosis. I. Involvement of at least two distinct pathways, J. Immunol., 161, 1758, 10.4049/jimmunol.161.4.1758 Geldhof, 1995, Expression of B7-1 by highly metastatic mouse T lymphomas induces optimal natural killer cell-mediated cytotoxicity, Cancer Res., 55, 2730 Gruber, 2002, Requirement for NK cells in CD40 ligand-mediated rejection of Philadelphia chromosome-positive acute lymphoblastic leukemia cells, J. Immunol., 168, 73, 10.4049/jimmunol.168.1.73 Hashimoto, 1999, Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas–Fas ligand- and perforin-induced tumor apoptosis, respectively, J. Immunol., 163, 583, 10.4049/jimmunol.163.2.583 Hayakawa, 2002, Cutting edge: tumor rejection mediated by NKG2D receptor–ligand interaction is dependent upon perforin, J. Immunol., 169, 5377, 10.4049/jimmunol.169.10.5377 Hayakawa, 2004, NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy, J. Immunol., 172, 123, 10.4049/jimmunol.172.1.123 Heusel, 1994, Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells, Cell, 76, 977, 10.1016/0092-8674(94)90376-X Hutloff, 1999, ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28, Nature, 397, 263, 10.1038/16717 Jamieson, 2002, The role of the NKG2D immunoreceptor in immune cell activation and natural killing, Immunity, 17, 19, 10.1016/S1074-7613(02)00333-3 Kagi, 1994, Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice, Nature, 369, 31, 10.1038/369031a0 Kelly, 2002, Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection, Nat. Immunol., 3, 83, 10.1038/ni746 Kelly, 1996, Cloning and expression of the recombinant mouse natural killer cell granzyme Met-ase-1, Immunogenetics, 44, 340, 10.1007/BF02602778 Kelly, 2002, A role for IFN-gamma in primary and secondary immunity generated by NK cell-sensitive tumor-expressing CD80 in vivo, J. Immunol., 168, 4472, 10.4049/jimmunol.168.9.4472 Kelly, 2004, Granzyme M mediates a novel form of perforin-dependent cell death, J. Biol. Chem., 279, 22236, 10.1074/jbc.M401670200 Krmpotic, 2002, MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo, Nat. Immunol., 3, 529, 10.1038/ni799 Lanier, 1998, NK cell receptors, Annu. Rev. Immunol., 16, 359, 10.1146/annurev.immunol.16.1.359 Lee, 2001, Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily, Nat. Genet., 28, 42, 10.1038/ng0501-42 Lens, 1998, Control of lymphocyte function through CD27–CD70 interactions, Semin. Immunol., 10, 491, 10.1006/smim.1998.0154 Lodoen, 2003, NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules, J. Exp. Med., 197, 1245, 10.1084/jem.20021973 Martin-Fontecha, 1999, Triggering of murine NK cells by CD40 and CD86 (B7-2), J. Immunol., 162, 5910, 10.4049/jimmunol.162.10.5910 Metkar, 2002, Cytotoxic cell granule-mediated apoptosis: perforin delivers granzyme B–serglycin complexes into target cells without plasma membrane pore formation, Immunity, 16, 417, 10.1016/S1074-7613(02)00286-8 Motyka, 2000, Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis, Cell, 103, 491, 10.1016/S0092-8674(00)00140-9 Mullbacher, 1999, Perforin is essential for control of ectromelia virus but not related poxviruses in mice, J. Virol., 73, 1665, 10.1128/JVI.73.2.1665-1667.1999 Mullbacher, 1999, Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes, Proc. Natl. Acad. Sci. U.S.A., 96, 13950, 10.1073/pnas.96.24.13950 Nakajima, 1998, Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7, J. Immunol., 161, 1901, 10.4049/jimmunol.161.4.1901 Odeberg, 2003, The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins, J. Virol., 77, 4539, 10.1128/JVI.77.8.4539-4545.2003 Ogasawara, 2002, Inducible costimulator costimulates cytotoxic activity and IFN-gamma production in activated murine NK cells, J. Immunol., 169, 3676, 10.4049/jimmunol.169.7.3676 Pham, 1999, Dipeptidyl peptidase I is required for the processing and activation of granzymes A and B in vivo, Proc. Natl. Acad. Sci. U.S.A., 96, 8627, 10.1073/pnas.96.15.8627 Pham, 1996, Long-range disruption of gene expression by a selectable marker cassette, Proc. Natl. Acad. Sci. U.S.A., 93, 13090, 10.1073/pnas.93.23.13090 Portales, 2003, Perforin expression in T cells and virological response to PEG-interferon alpha2b in HIV-1 infection, Aids, 17, 505, 10.1097/00002030-200303070-00005 Rukamp, 2004, Subsite specificities of granzyme M: a study of inhibitors and newly synthesized thiobenzyl ester substrates, Arch. Biochem. Biophys., 422, 9, 10.1016/j.abb.2003.12.005 Sato, 2001, Antiviral response by natural killer cells through TRAIL gene induction by IFN-alpha/beta, Eur. J. Immunol., 31, 3138, 10.1002/1521-4141(200111)31:11<3138::AID-IMMU3138>3.0.CO;2-B Scalzo, 1990, Cmv-1, a genetic locus that controls murine cytomegalovirus replication in the spleen, J. Exp. Med., 171, 1469, 10.1084/jem.171.5.1469 Screpanti, 2001, A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells, J. Immunol., 167, 2068, 10.4049/jimmunol.167.4.2068 Seki, 2003, Tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer, Cancer Res., 63, 207 Shi, 1992, Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions, J. Exp. Med., 176, 1521, 10.1084/jem.176.6.1521 Smith, 2002, Recognition of a virus-encoded ligand by a natural killer cell activation receptor, Proc. Natl. Acad. Sci. U.S.A., 99, 8826, 10.1073/pnas.092258599 Smith, 1998, Ly-49D and Ly-49H associate with mouse DAP12 and form activating receptors, J. Immunol., 161, 7, 10.4049/jimmunol.161.1.7 Smyth, 2001, Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis, J. Exp. Med., 193, 661, 10.1084/jem.193.6.661 Smyth, 2002, New aspects of natural-killer-cell surveillance and therapy of cancer, Nat. Rev. Cancer, 2, 850, 10.1038/nrc928 Smyth, 1999, Multiple deficiencies underlie NK cell inactivity in lymphotoxin-alpha gene-targeted mice, J. Immunol., 163, 1350, 10.4049/jimmunol.163.3.1350 Smyth, 1998, An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum, J. Exp. Med., 188, 1611, 10.1084/jem.188.9.1611 Smyth, 1995, Expression of recombinant human granzyme B. A processing and activation role for dipeptidyl peptidase I, J. Immunol., 154, 6299, 10.4049/jimmunol.154.12.6299 Smyth, 1996, Granzymes: a variety of serine protease specificities encoded by genetically distinct subfamilies, J. Leukoc. Biol., 60, 555, 10.1002/jlb.60.5.555 Smyth, 1993, Met-ase: cloning and distinct chromosomal location of a serine protease preferentially expressed in human natural killer cells, J. Immunol., 151, 6195, 10.4049/jimmunol.151.11.6195 Smyth, 2003, Cutting edge: granzymes A and B are not essential for perforin-mediated tumor rejection, J. Immunol., 171, 515, 10.4049/jimmunol.171.2.515 Smyth, 2003, Nature's TRAIL – on a path to cancer immunotherapy, Immunity, 18, 1, 10.1016/S1074-7613(02)00502-2 Smyth, 2000, The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent, J. Immunol., 165, 2665, 10.4049/jimmunol.165.5.2665 Smyth, 1999, Perforin is a major contributor to NK cell control of tumor metastasis, J. Immunol., 162, 6658, 10.4049/jimmunol.162.11.6658 Smyth, 2000, Differential tumor surveillance by natural killer (NK) and NKT cells, J. Exp. Med., 191, 661, 10.1084/jem.191.4.661 Smyth, 1995, Granzymes: exogenous proteinases that induce target cell apoptosis, Immunol. Today, 16, 202, 10.1016/0167-5699(95)80122-7 Smyth, 1992, Purification and cloning of a novel serine protease, RNK-Met-1, from the granules of a rat natural killer cell leukemia, J. Biol. Chem., 267, 24418, 10.1016/S0021-9258(18)35783-1 Stenger, 1998, An antimicrobial activity of cytolytic T cells mediated by granulysin, Science, 282, 121, 10.1126/science.282.5386.121 Stepp, 1999, Perforin gene defects in familial hemophagocytic lymphohistiocytosis, Science, 286, 1957, 10.1126/science.286.5446.1957 Street, 2001, Perforin and interferon-gamma activities independently control tumor initiation, growth, and metastasis, Blood, 97, 192, 10.1182/blood.V97.1.192 Street, 2004, Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and {gamma}{delta} T cells, J. Exp. Med., 199, 879, 10.1084/jem.20031981 Takeda, 2001, Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells, Nat. Med., 7, 94, 10.1038/83416 Takeda, 2000, CD27-mediated activation of murine NK cells, J. Immunol., 164, 1741, 10.4049/jimmunol.164.4.1741 Takeda, 2002, Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development, J. Exp. Med., 195, 161, 10.1084/jem.20011171 Takeda, 2001, Involvement of tumor necrosis factor-related apoptosis-inducing ligand in NK cell-mediated and IFN-gamma-dependent suppression of subcutaneous tumor growth, Cell. Immunol., 214, 194, 10.1006/cimm.2001.1896 Tay, 1997, Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells, J. Virol., 71, 267, 10.1128/JVI.71.1.267-275.1997 Tomasello, 1998, Gene structure, expression pattern, and biological activity of mouse killer cell activating receptor-associated protein (KARAP)/DAP-12, J. Biol. Chem., 273, 34115, 10.1074/jbc.273.51.34115 Trapani, 1996, Localization of granzyme B in the nucleus. A putative role in the mechanism of cytotoxic lymphocyte-mediated apoptosis, J. Biol. Chem., 271, 4127, 10.1074/jbc.271.8.4127 Trapani, 2000, Proapoptotic functions of cytotoxic lymphocyte granule constituents in vitro and in vivo, Curr. Opin. Immunol., 12, 323, 10.1016/S0952-7915(00)00094-7 Trapani, 2002, Functional significance of the perforin/granzyme cell death pathway, Nat. Rev. Immunol., 2, 735, 10.1038/nri911 Turner, 2001, Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells, J. Immunol., 166, 89, 10.4049/jimmunol.166.1.89 van den Broek, 1995, Perforin dependence of natural killer cell-mediated tumor control in vivo, Eur. J. Immunol., 25, 3514, 10.1002/eji.1830251246 Westwood, 2004, Cutting edge: novel priming of tumor-specific immunity by NKG2D-triggered NK cell-mediated tumor rejection and Th1-independent CD4+ T cell pathway, J. Immunol., 172, 757, 10.4049/jimmunol.172.2.757 Yokoyama, 1995, A family of murine NK cell receptors specific for target cell MHC class I molecules, Semin. Immunol., 7, 89, 10.1006/smim.1995.0013 Yoshinaga, 1999, T-cell co-stimulation through B7RP-1 and ICOS, Nature, 402, 827, 10.1038/45582 Zompi, 2003, NKG2D triggers cytotoxicity in mouse NK cells lacking DAP12 or Syk family kinases, Nat. Immunol., 4, 565, 10.1038/ni930